ATE358510T1 - Vorrichtung zur iontophoretischen verabreichung von medikamenten durch das augenlid - Google Patents

Vorrichtung zur iontophoretischen verabreichung von medikamenten durch das augenlid

Info

Publication number
ATE358510T1
ATE358510T1 AT02790508T AT02790508T ATE358510T1 AT E358510 T1 ATE358510 T1 AT E358510T1 AT 02790508 T AT02790508 T AT 02790508T AT 02790508 T AT02790508 T AT 02790508T AT E358510 T1 ATE358510 T1 AT E358510T1
Authority
AT
Austria
Prior art keywords
eyelid
medication
iontophoretic administration
designed
main electrode
Prior art date
Application number
AT02790508T
Other languages
English (en)
Inventor
Francine Behar
Pierre Roy
Original Assignee
Eyegate Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyegate Pharma Sa filed Critical Eyegate Pharma Sa
Application granted granted Critical
Publication of ATE358510T1 publication Critical patent/ATE358510T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02790508T 2001-10-12 2002-10-11 Vorrichtung zur iontophoretischen verabreichung von medikamenten durch das augenlid ATE358510T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0113176A FR2830766B1 (fr) 2001-10-12 2001-10-12 Dispositif de delivrance de medicaments par iontophorese transpalpebrale

Publications (1)

Publication Number Publication Date
ATE358510T1 true ATE358510T1 (de) 2007-04-15

Family

ID=8868226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02790508T ATE358510T1 (de) 2001-10-12 2002-10-11 Vorrichtung zur iontophoretischen verabreichung von medikamenten durch das augenlid

Country Status (16)

Country Link
US (3) US7848800B2 (de)
EP (1) EP1434622B1 (de)
JP (1) JP4184275B2 (de)
KR (1) KR20050035158A (de)
AT (1) ATE358510T1 (de)
BR (1) BR0213249A (de)
CA (1) CA2463362C (de)
CY (1) CY1106671T1 (de)
DE (1) DE60219336T2 (de)
DK (1) DK1434622T3 (de)
ES (1) ES2283628T3 (de)
FR (1) FR2830766B1 (de)
IL (1) IL161298A0 (de)
MX (1) MXPA04003438A (de)
PT (1) PT1434622E (de)
WO (1) WO2003030989A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US20090088721A1 (en) * 2001-04-17 2009-04-02 Eyegate Pharma S.A.S. Enhanced retinal delivery of a nucleic acid through iontophoresis
US9994853B2 (en) 2001-05-18 2018-06-12 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
US9657294B2 (en) 2002-02-20 2017-05-23 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
US9181551B2 (en) 2002-02-20 2015-11-10 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
KR20080018980A (ko) 2004-04-30 2008-02-29 아이게이트 파르마 에스아에스 자극 감소형의 안구용 이온 영동 장치
FR2869531B1 (fr) * 2004-04-30 2006-07-14 Optis France Sa Sa Dispositif de iontophorese oculaire diminuant les irritations
US10508277B2 (en) 2004-05-24 2019-12-17 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
US8246949B2 (en) * 2004-10-27 2012-08-21 Aciont, Inc. Methods and devices for sustained in-vivo release of an active agent
US20070260171A1 (en) * 2005-09-27 2007-11-08 Higuchi John W Intraocular iontophoretic device and associated methods
US8755880B2 (en) * 2005-10-24 2014-06-17 Aciont, Inc. Intraocular iontophoretic device and associated methods
US8634907B2 (en) * 2005-10-24 2014-01-21 Aciont, Inc. Intraocular iontophoretic device and associated methods
JP5128932B2 (ja) * 2007-12-28 2013-01-23 日立マクセル株式会社 美容機器
MX2011006925A (es) 2008-12-31 2011-07-28 Eyegate Pharma S A S Sistema y metodo de iontoforesis ocular con amortiguacion.
EP2408458A1 (de) 2009-03-19 2012-01-25 Merck Sharp&Dohme Corp. Rna-schnittstellen-vermittelte unterdrückung der signal transducer and activator of transcription 6 (stat6) genexpression mit short interfering nucleic acid (sina)
EP2408916A2 (de) 2009-03-19 2012-01-25 Merck Sharp&Dohme Corp. Rna-interferenz-vermittelte hemmung der genexpression von ctgf (connective tissue growth factor) unter verwendung von sina (short interfering nucleic acid)
WO2010107957A2 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
CA2755773A1 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. Rna interference mediated inhibition of btb and cnc homology 1, basic leucine zipper transcription factor 1 (bach 1) gene expression using short interfering nucleic acid (sina)
WO2010111464A1 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
JP2012521762A (ja) 2009-03-27 2012-09-20 メルク・シャープ・エンド・ドーム・コーポレイション 低分子干渉核酸（ｓｉＮＡ）を用いた神経成長因子β鎖（ＮＧＦβ）遺伝子発現のＲＮＡ干渉媒介性阻害
EP2411520A2 (de) 2009-03-27 2012-02-01 Merck Sharp&Dohme Corp. Rna-interferenz-vermittelte hemmung der genexpression von tslp (thymic stromal lymphopoietin) unter verwendung von sina (short interfering nucleic acid)
SG174581A1 (en) 2009-03-27 2011-10-28 Merck Sharp & Dohme RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP2411019A2 (de) 2009-03-27 2012-02-01 Merck Sharp&Dohme Corp. Rna-interferenz-vermittelte hemmung der signal transducer and activator of transcription 1 (stat1) gen-expression mittels sina (short interfering nucleic acid)
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
JP2011018873A (ja) * 2009-05-22 2011-01-27 Sony Ericsson Mobilecommunications Japan Inc 電磁シールド方法および電磁シールド用フィルム
EP2590669B1 (de) 2010-07-09 2016-08-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Behandlung von krankheiten im zusammenhang mit degenerativen netzhautstörungen
US8518907B2 (en) 2010-08-02 2013-08-27 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
EP2606134B1 (de) 2010-08-17 2019-04-10 Sirna Therapeutics, Inc. Rna-interferenz-vermittelte hemmung der hepatitis b-virus (hbv)-genexpression mittels kurzer interferierender nukleinsäure (sina)
EP2609106A4 (de) 2010-08-26 2014-03-19 Merck Sharp & Dohme Durch rna-interferenz vermittelte inhibition der prolyl-hydroxylase-domäne-2 (phd2)-genexpression unter verwendung von short-interfering-nukleinsäuren (sina)
EP3766975A1 (de) 2010-10-29 2021-01-20 Sirna Therapeutics, Inc. Rna-interferenz-vermittelte inhibition von genexpression unter verwendung kurzer interferierender nukleinsäure (sina)
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
WO2013165816A2 (en) 2012-05-02 2013-11-07 Merck Sharp & Dohme Corp. SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
US9884886B2 (en) 2012-12-06 2018-02-06 Merck Sharp & Dohme Disulfide masked prodrug compositions and methods
EP3148491B1 (de) 2014-05-29 2020-07-01 Glaukos Corporation Implantate mit kontrollierter arzneimittelfreisetzung und herstellungsverfahren davon
US9937074B2 (en) 2015-01-22 2018-04-10 Eyegate Pharmaceuticals, Inc. Iontophoretic contact lens
US20180125947A1 (en) 2015-05-20 2018-05-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Treatment of retinal detachment
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
CN115120405A (zh) 2016-04-20 2022-09-30 多斯医学公司 生物可吸收眼部药物的递送装置
US11787783B2 (en) 2016-12-13 2023-10-17 Beta Therapeutics Pty Ltd Heparanase inhibitors and use thereof
RU2019121873A (ru) 2016-12-13 2021-01-15 БЕТА ТЕРАПЬЮТИКС ПиТиУай ЛТД Ингибиторы гепараназы и их применение
IT201700014315A1 (it) * 2017-02-09 2018-08-09 Bruno Massimo Cetroni Dispositivo per il trasporto intracellulare in biorisonanza
KR101889357B1 (ko) * 2017-09-20 2018-08-17 (주)휴비딕 눈의 나노 약물 전달용 이온공급 장치

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845757A (en) * 1972-07-12 1974-11-05 Minnesota Mining & Mfg Biomedical monitoring electrode
US4564016A (en) * 1982-05-24 1986-01-14 The Board Of Trustees Of The Leland Stanford Junior University Apparatus for introducing ionized drugs into the posterior segment of the eye and method
US4603076A (en) * 1985-03-04 1986-07-29 Norwood Industries, Inc. Hydrophilic foam
US5320597A (en) * 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
US5169384A (en) * 1991-08-16 1992-12-08 Bosniak Stephen L Apparatus for facilitating post-traumatic, post-surgical, and/or post-inflammatory healing of tissue
US5356632A (en) * 1991-09-12 1994-10-18 S.I. Scientific Innovations Ltd. Transdermal drug delivery device
AU652494B2 (en) * 1991-11-15 1994-08-25 Minnesota Mining And Manufacturing Company Solid state conductive polymer compositions, biomedical electrodes containing such compositions, and method of preparing same
US5450845A (en) * 1993-01-11 1995-09-19 Axelgaard; Jens Medical electrode system
US5522864A (en) * 1994-10-25 1996-06-04 Wallace; Larry B. Apparatus and method for ocular treatment
AUPM982694A0 (en) * 1994-12-02 1995-01-05 University Of Queensland, The Iontophoresis method and apparatus
FR2773320B1 (fr) * 1998-01-05 2000-03-03 Optisinvest Dispositif pour le transfert intraoculaire de produits actifs par iontophorese
IL123290A (en) 1998-02-13 2001-12-23 Hadasit Med Res Service Iontophoretic device
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6477410B1 (en) * 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
US6277401B1 (en) * 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
US6728573B1 (en) * 2000-02-23 2004-04-27 Iomed, Inc. Ocular iontophoretic apparatus handle
US6697668B2 (en) * 2001-01-25 2004-02-24 Iomed, Inc. Ocular iontophoretic device and method for using the same
US6546284B2 (en) * 2001-01-25 2003-04-08 Iomed, Inc. Fluid retention assembly for an iontophoretic delivery device and associated method for preparing the same
US20040106965A1 (en) * 2001-06-29 2004-06-03 Chow Alan Y. Methods and apparatus for treatment of degenerative retinal disease via indirect electrical stimulation
US20030023228A1 (en) * 2001-07-20 2003-01-30 Parkinson Thomas M. Ocular iontophoretic device and method for using the same
US6694193B2 (en) * 2001-09-14 2004-02-17 Koninklijke Philips Electronics N.V. Medical electrode and release liner configurations facilitating packaged electrode characterization

Also Published As

Publication number Publication date
ES2283628T3 (es) 2007-11-01
US7848800B2 (en) 2010-12-07
FR2830766B1 (fr) 2004-03-12
JP2005504612A (ja) 2005-02-17
US20040267188A1 (en) 2004-12-30
JP4184275B2 (ja) 2008-11-19
DE60219336D1 (de) 2007-05-16
EP1434622A2 (de) 2004-07-07
DK1434622T3 (da) 2007-08-13
IL161298A0 (en) 2004-09-27
US8771256B2 (en) 2014-07-08
MXPA04003438A (es) 2005-02-17
CY1106671T1 (el) 2012-05-23
CA2463362A1 (fr) 2003-04-17
BR0213249A (pt) 2004-09-28
US20140323947A1 (en) 2014-10-30
EP1434622B1 (de) 2007-04-04
US9192512B2 (en) 2015-11-24
US20110098632A1 (en) 2011-04-28
PT1434622E (pt) 2007-07-11
DE60219336T2 (de) 2007-12-20
KR20050035158A (ko) 2005-04-15
FR2830766A1 (fr) 2003-04-18
WO2003030989A2 (fr) 2003-04-17
WO2003030989A3 (fr) 2003-10-30
CA2463362C (fr) 2011-04-19

Similar Documents

Publication Publication Date Title
ATE358510T1 (de) Vorrichtung zur iontophoretischen verabreichung von medikamenten durch das augenlid
WO2007035710A3 (en) Electrokinetic delivery system and methods therefor
CA2413806A1 (en) Electrokinetic delivery device
DK1301123T3 (da) Hudelektrode med et bypass-element
ATE346377T1 (de) Rhodium-reiche sauerstoffbarrieren
ATE455497T1 (de) Medizinische elektrode und herstellungsverfahren
AU6207101A (en) An electrode for establishing electrical contact with the skin
DE60225822D1 (de) Vorrichtung zur verabreichung von medikamenten durch intraokulare iontophorese oder electroporation
ATE279232T1 (de) Iontophoretische elektrodenvorrichtung mit geringem anfangswiderstand
DE602004023300D1 (de) Diamant-mikroelektroden
ATE295161T1 (de) Wirstoffmischung in vagal-induzierter asystolie
WO2008042404A3 (en) Electrokinetic system and method for delivering methotrexate
SE0002834D0 (sv) Electrochromic device based on nanochrystalline materials
ES2194222T3 (es) Dispositivo para la administracion asistida electricamente de agentes tales como lidocaina y epinefrina.
ATE125856T1 (de) Elektrisch leitfähiger klebstoff.
DE60123052D1 (de) Elektro-adhäsions-vorrichtung
ATE153244T1 (de) Benutzeraktivierte, iontophoretische vorrichtung
MX170809B (es) Electrodo de iontoforesis
ATE259664T1 (de) Vorrichtung zur pflege von kontaktlinsen
WO1998000118A3 (en) Drug delivery devices and process of manufacture
ES1050240U (es) Conjunto de electrodos para aparatos de electroterapia.
SE0302007D0 (sv) New Matter
ES1052817U (es) Conjunto de electrodos para aparatos de electroterapia.
EA200500538A1 (ru) Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы
SE9700537L (sv) Strömbegränsare

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1434622

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee